Antiarrhythmic Drug Therapy
Antiarrhythmic Drug Therapy is a pharmaceutical drug with 7 clinical trials. Historical success rate of 66.7%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
66.7%
2 of 3 finished
33.3%
1 ended early
0
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Anti-arrhythmic Therapy vs Catheter Ablation as First Line Treatment for AICD Shock Prevention
FLAT Study: First Line Ablation Therapy for Treatment of Paroxysmal Atrial Fibrillation (RAAFT)
CAB Versus Medical Therapy in Patients With AF and HF With Different EF Categories
Early Aggressive Invasive Intervention for Atrial Fibrillation
The Impact of "First-Line" Rhythm Therapy on AF Progression
Clinical Trials (7)
Anti-arrhythmic Therapy vs Catheter Ablation as First Line Treatment for AICD Shock Prevention
FLAT Study: First Line Ablation Therapy for Treatment of Paroxysmal Atrial Fibrillation (RAAFT)
CAB Versus Medical Therapy in Patients With AF and HF With Different EF Categories
Early Aggressive Invasive Intervention for Atrial Fibrillation
The Impact of "First-Line" Rhythm Therapy on AF Progression
Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Ischemic Ventricular Tachyarrhythmias
A Trial of Circumferential Pulmonary Vein Ablation (CPVA) Versus Antiarrhythmic Drug Therapy in for Paroxysmal Atrial Fibrillation (AF)
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7